Beteiligungsmeldung
Molecular Partners AG
Gemeinsam gemeldeter Anteil
8.63%
Threshold
Crossed upwards
Timeline
Published
11.08.2015
Transaction
04.08.2015
Voting rights breakdown
Gemeldete wirtschaftlich Berechtigte · 2
Eine einzelne, gemeinsam eingereichte Meldung: Der Stimmrechtsanteil gilt für die gesamte Gruppe, nicht für jede Person.
Notice details
Meldungs-ID
TBF8A00017
Beneficial owner
Johnson & Johnson
Gemeldete Adresse
Johnson & Johnson, New Brunswick, New Jersey 08933
End of lock-up period on August 4, 2015 pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). 100% of the shares/voting rights in Johnson & Johnson Innovation-JJDC, Inc. (formerly known as Johnson & Johnson Development Corporation) are held by Johnson & Johnson.
insider24.ch
Verpassen Sie kein Marktsignal mehr
Mehr benötigt? Pro-Angebot entdecken